Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Neu

Infection

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Infection|January 1, 1980
Optimal antibiotic therapy in bronchopulmonary infectionsH C Neu
Infection|January 1, 1992
Optimal characteristics of agents to treat uncomplicated urinary tract infectionsH C Neu
Infection|January 1, 1979
Endocarditis: the problems remain and multiplyH C Neu
Infection|January 1, 1983
What do beta-lactamases mean for clinical efficacy?H C Neu
Infection|January 1, 1991
Cephalosporins--cefotaxime 10 years later, a major drug with continued useH C Neu
Infection|January 1, 1980
Fluid management in Haemophilus influenzae meningitisA S Prince, H C Neu
Infection|May 1, 1985
The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosaH C Neu, N X Chin, P Labthavikul
Infection|May 1, 1987
Streptococcus agalactiae (group B) endocarditis--a description of twelve cases and review of the literatureB E Scully, D Spriggs, H C Neu
Infection|January 1, 1978
Therapy of serious infections with cefamandoleM F Parry, M J Goldberger, H C Neu
Infection|November 1, 1983
The use of moxalactam in the treatment of serious infections due to multi-resistant organismsS Srinivasan, E L Francke, C Ortiz-Neu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Infection|January 1, 1980
Optimal antibiotic therapy in bronchopulmonary infectionsH C Neu
Infection|January 1, 1992
Optimal characteristics of agents to treat uncomplicated urinary tract infectionsH C Neu
Infection|January 1, 1979
Endocarditis: the problems remain and multiplyH C Neu
Infection|January 1, 1983
What do beta-lactamases mean for clinical efficacy?H C Neu
Infection|January 1, 1991
Cephalosporins--cefotaxime 10 years later, a major drug with continued useH C Neu
Infection|January 1, 1980
Fluid management in Haemophilus influenzae meningitisA S Prince, H C Neu
Infection|May 1, 1985
The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosaH C Neu, N X Chin, P Labthavikul
Infection|May 1, 1987
Streptococcus agalactiae (group B) endocarditis--a description of twelve cases and review of the literatureB E Scully, D Spriggs, H C Neu
Infection|January 1, 1978
Therapy of serious infections with cefamandoleM F Parry, M J Goldberger, H C Neu
Infection|November 1, 1983
The use of moxalactam in the treatment of serious infections due to multi-resistant organismsS Srinivasan, E L Francke, C Ortiz-Neu, et al.
Pageof 2